secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001193125-24-092520
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eliem to acquire Tenet Medicines in stock deal; raises $120M PIPE at $3.84/share
--------------------------------------------------------------------------------

- Eliem (ELYM) acquires Tenet via merger; Tenet holders get 15.4% of combined co. stock.
- PIPE raises $120M from accredited investors at $3.84/share; closes after merger.
- Stephen Thomas (Tenet CEO) to become interim CEO; William Bonificio interim CBO.
- Combined board expands to 7 members: 5 current Eliem directors, Thomas, and 1 Tenet designee.
- Deal requires disinterested stockholder vote; termination fee of $1M payable under certain conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312524092520/0001193125-24-092520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312524092520/d737147d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-092520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer